Molecular remodeling of the renin-angiotensin system after kidney transplantation

Objective: We aimed at assessing the molecular adaptation of the renin-angiotensin system (RAS) after successful kidney transplantation (KTX). Materials and methods: In this prospective, exploratory study we analyzed 12 hemodialysis (HD) patients, who received a KTX and had excellent graft function...

Full description

Bibliographic Details
Main Authors: Marlies Antlanger, Oliver Domenig, Johannes J Kovarik, Christopher C Kaltenecker, Chantal Kopecky, Marko Poglitsch, Marcus D Säemann
Format: Article
Language:English
Published: Hindawi - SAGE Publishing 2017-05-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.1177/1470320317705232
id doaj-c0ba3defa6b1478c89613e0b60563f2a
record_format Article
spelling doaj-c0ba3defa6b1478c89613e0b60563f2a2021-05-02T21:31:38ZengHindawi - SAGE PublishingJournal of the Renin-Angiotensin-Aldosterone System1752-89762017-05-011810.1177/147032031770523210.1177_1470320317705232Molecular remodeling of the renin-angiotensin system after kidney transplantationMarlies Antlanger0Oliver Domenig1Johannes J Kovarik2Christopher C Kaltenecker3Chantal Kopecky4Marko Poglitsch5Marcus D Säemann6Medical University of Vienna, Department of Internal Medicine III, Clinical Division of Nephrology and Dialysis, AustriaMedical University of Vienna, Department of Internal Medicine III, Clinical Division of Nephrology and Dialysis, AustriaMedical University of Vienna, Department of Internal Medicine III, Clinical Division of Nephrology and Dialysis, AustriaMedical University of Vienna, Department of Internal Medicine III, Clinical Division of Nephrology and Dialysis, AustriaMedical University of Vienna, Department of Internal Medicine III, Clinical Division of Nephrology and Dialysis, AustriaAttoquant Diagnostics, AustriaMedical University of Vienna, Department of Internal Medicine III, Clinical Division of Nephrology and Dialysis, AustriaObjective: We aimed at assessing the molecular adaptation of the renin-angiotensin system (RAS) after successful kidney transplantation (KTX). Materials and methods: In this prospective, exploratory study we analyzed 12 hemodialysis (HD) patients, who received a KTX and had excellent graft function six to 12 months thereafter. The concentrations of plasma Angiotensin (Ang) peptides (Ang I, Ang II, Ang-(1–7), Ang-(1–5), Ang-(2–8), Ang-(3–8)) were simultaneously quantified with a novel mass spectrometry-based method. Further, renin and aldosterone concentrations were determined by standard immunoassays. Results: Ang values showed a strong inter-individual variability among HD patients. Yet, despite a continued broad dispersion of Ang values after KTX, a substantial improvement of the renin/Ang II correlation was observed in patients without RAS blockade or on angiotensin receptor blocker (HD: renin/Ang II R 2 = 0.660, KTX: renin/Ang II R 2 = 0.918). Ang-(1–7) representing the alternative RAS axis was only marginally detectable both on HD and after KTX. Conclusions: Following KTX, renin-dependent Ang II formation adapts in non-ACE inhibitor-treated patients. Thus, a largely normal RAS regulation is reconstituted after successful KTX. However, individual Ang concentration variations and a lack of potentially beneficial alternative peptides after KTX call for individualized treatment. The long-term post-transplant RAS regulation remains to be determined.https://doi.org/10.1177/1470320317705232
collection DOAJ
language English
format Article
sources DOAJ
author Marlies Antlanger
Oliver Domenig
Johannes J Kovarik
Christopher C Kaltenecker
Chantal Kopecky
Marko Poglitsch
Marcus D Säemann
spellingShingle Marlies Antlanger
Oliver Domenig
Johannes J Kovarik
Christopher C Kaltenecker
Chantal Kopecky
Marko Poglitsch
Marcus D Säemann
Molecular remodeling of the renin-angiotensin system after kidney transplantation
Journal of the Renin-Angiotensin-Aldosterone System
author_facet Marlies Antlanger
Oliver Domenig
Johannes J Kovarik
Christopher C Kaltenecker
Chantal Kopecky
Marko Poglitsch
Marcus D Säemann
author_sort Marlies Antlanger
title Molecular remodeling of the renin-angiotensin system after kidney transplantation
title_short Molecular remodeling of the renin-angiotensin system after kidney transplantation
title_full Molecular remodeling of the renin-angiotensin system after kidney transplantation
title_fullStr Molecular remodeling of the renin-angiotensin system after kidney transplantation
title_full_unstemmed Molecular remodeling of the renin-angiotensin system after kidney transplantation
title_sort molecular remodeling of the renin-angiotensin system after kidney transplantation
publisher Hindawi - SAGE Publishing
series Journal of the Renin-Angiotensin-Aldosterone System
issn 1752-8976
publishDate 2017-05-01
description Objective: We aimed at assessing the molecular adaptation of the renin-angiotensin system (RAS) after successful kidney transplantation (KTX). Materials and methods: In this prospective, exploratory study we analyzed 12 hemodialysis (HD) patients, who received a KTX and had excellent graft function six to 12 months thereafter. The concentrations of plasma Angiotensin (Ang) peptides (Ang I, Ang II, Ang-(1–7), Ang-(1–5), Ang-(2–8), Ang-(3–8)) were simultaneously quantified with a novel mass spectrometry-based method. Further, renin and aldosterone concentrations were determined by standard immunoassays. Results: Ang values showed a strong inter-individual variability among HD patients. Yet, despite a continued broad dispersion of Ang values after KTX, a substantial improvement of the renin/Ang II correlation was observed in patients without RAS blockade or on angiotensin receptor blocker (HD: renin/Ang II R 2 = 0.660, KTX: renin/Ang II R 2 = 0.918). Ang-(1–7) representing the alternative RAS axis was only marginally detectable both on HD and after KTX. Conclusions: Following KTX, renin-dependent Ang II formation adapts in non-ACE inhibitor-treated patients. Thus, a largely normal RAS regulation is reconstituted after successful KTX. However, individual Ang concentration variations and a lack of potentially beneficial alternative peptides after KTX call for individualized treatment. The long-term post-transplant RAS regulation remains to be determined.
url https://doi.org/10.1177/1470320317705232
work_keys_str_mv AT marliesantlanger molecularremodelingofthereninangiotensinsystemafterkidneytransplantation
AT oliverdomenig molecularremodelingofthereninangiotensinsystemafterkidneytransplantation
AT johannesjkovarik molecularremodelingofthereninangiotensinsystemafterkidneytransplantation
AT christopherckaltenecker molecularremodelingofthereninangiotensinsystemafterkidneytransplantation
AT chantalkopecky molecularremodelingofthereninangiotensinsystemafterkidneytransplantation
AT markopoglitsch molecularremodelingofthereninangiotensinsystemafterkidneytransplantation
AT marcusdsaemann molecularremodelingofthereninangiotensinsystemafterkidneytransplantation
_version_ 1721487245189316608